Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
989
datasets available to search
ShareScore release 0.9.0
Dataset results
989 results for “myelodysplastic syndrome”
Affymetrix SNP array data for myelodysplastic syndromes (MDS) samples
GEO Series GSE73005. Homo sapiens. 14 samples. Type: Genome variation profiling by SNP array.
Multi-omics analysis of myelodysplastic syndromes resistance to epigenetics threrary reveals PI3K/Akt activation mediated by epigenetic silencing of PTEN and epi-transcriptional silencing of MDM2
GEO Series GSE165188. Homo sapiens. 10 samples. Type: Methylation profiling by high throughput sequencing; Methylation profiling by genome tiling array; Expression profiling by high throughput sequencing.
Gene expression data from bone marrow CD34+ cells of patients with myelodysplastic syndromes (MDS) and healthy controls
GEO Series GSE58831. Homo sapiens. 176 samples. Type: Expression profiling by array.
SIRT1 Activation Disrupts Maintenance of Myelodysplastic Syndrome Stem and Progenitor Cells by Restoring TET2 Function [hMeDIP-Seq]
GEO Series GSE117363. Homo sapiens. 6 samples. Type: Methylation profiling by high throughput sequencing.
Acquired mutations in TET2 are common in myelodysplastic syndromes
GEO Series GSE15688. Homo sapiens. 122 samples. Type: Genome variation profiling by SNP array.
Methylation profiling of Low-Risk Myelodysplastic Syndromes (MDSs)
GEO Series GSE41215. Homo sapiens. 20 samples. Type: Methylation profiling by genome tiling array.
Study of Clofarabine in Combination With Low Dose Cytarabine to Treat Myelodysplastic Syndromes
ClinicalTrials.gov study NCT01302106. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 2 Study Evaluating Olutasidenib in Combination With Hypomethylating Agents in Patients With IDH1-mutated Higher-risk Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Advanced Mye
ClinicalTrials.gov study NCT06597734. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of FF-10501-01 in Combination with Azacitidine in Patients with Myelodysplastic Syndrome
ClinicalTrials.gov study NCT03486353. IPD Sharing: NO. Countries: 0. Publications: 0.
Efficacy & Safety Study of KPT-330 in Erythropoietin-Refractory Lower-Risk Myelodysplastic Syndrome Patients
ClinicalTrials.gov study NCT02431351. IPD Sharing: Not stated. Countries: 0. Publications: 0.
TMLI/Fludarabine/Melphalan Conditioning for Allogeneic Transplantation in High-risk Myelodysplastic Syndrome or Acute Myeloid Leukemia.
ClinicalTrials.gov study NCT06602323. IPD Sharing: NO. Countries: 0. Publications: 0.
Decitabine for Myelodysplastic Syndromes and Acute Myeloid Leukemia Before Allogeneic Hematopoietic Cell Transplantation
ClinicalTrials.gov study NCT01806116. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Study of Tipifarnib in Patients With High-Risk Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT00050154. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Phase 1 Trial of ASTX727 in Subjects With Lower-risk Myelodysplastic Syndromes
ClinicalTrials.gov study NCT03906695. IPD Sharing: NO. Countries: 1. Publications: 0.
QH101 Cell Therapy Relapsed/Refractory(R/R) Acute Myeloid Leukemia(AML) and Myelodysplastic Syndromes(MDS)
ClinicalTrials.gov study NCT07131085. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Pacritinib With Aza for Upfront Myelodysplastic Syndrome
ClinicalTrials.gov study NCT07387354. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Study to Evaluate the Safety, Pharmacokinetics and Clinical Activity of RP7214 in Combination With Azacitidine in Patients With Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia and Acute Myel
ClinicalTrials.gov study NCT05246384. IPD Sharing: NO. Countries: 0. Publications: 0.
Study of Lonafarnib Versus Placebo in Subjects With Either Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML) (Study P02978AM3)(TERMINATED)
ClinicalTrials.gov study NCT00109538. IPD Sharing: Not stated. Countries: 0. Publications: 0.
ASTX727 and FT-2102 in Treating IDH1-Mutated Recurrent/Refractory Myelodysplastic Syndrome or Acute Myeloid Leukemia
ClinicalTrials.gov study NCT04013880. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Phase 2 Study to Evaluate the Safety and Effectiveness of Once Weekly or Once Every Two Week Dosing of Epoetin Alfa in Anemic Patients With Low- or Intermediate-1 Risk Myelodysplastic Syndromes (MDS
ClinicalTrials.gov study NCT00446602. IPD Sharing: Not stated. Countries: 0. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.